$1,999.00

Quantity: ~1M viable cells
CIRM Line ID: CW10149
Disease: Healthy Donor
Gender: Male
Sampled age: 38
Ethinicity: Asian, not Latino

SKU: EXGS-QMSSVF-CW10149-1M Categories: , , Tag:

Description

Quantity: ~1M viable cells
CIRM Line ID: CW10149
Disease: Healthy Donor
Gender: Male
Sampled age: 38
Race: Asian, not Latino

Donor data

Demographic (source: CIRM) Description CONTROL: NO LIVER DISEASE | CHRONIC LUNG DISEASE (SELF-REPORTED): ASTHMA
Affected Status No
Product iPSC
Source PBMC
Sex Male
Age at Sampling 38 YR
Race Asian
Ethnicity Not Hispanic or Latino
Publications Cited 0
dbGap No
Biopsy Source Blood
Collection Control,Liver Diseases,Lung Diseases
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) LiverControl LiverControl
Diagnosis Healthy Control
Prior_Hospitalization Yes
If_yes_reason_for_hospitalization PNEUMONIA, KNEE SURGERY
Prior_Surgery Yes
If_yes_type_of_surgery KNEE, HAND
Alcohol_consumption 7 drinks per week
History_of_Hepatitis_A No
History_of_Hepatitis_B No
History_of_Hepatitis_C No
History_of_Other_Hepatitis No
History_of_Jaundice No
History_of_Mononucleosis No
History_of_HIV_Infection No
AST_IU/L_(range_10-41) 63
ALT_IU/L_(range_10-40) 47
Alkaline_phosphatase_mg/dL_(range_605-1536) 65
Bilirubin_mg/dL_(range_0.1-1.2) 0.4
HCV_antibody negative
PulmonarySharedControl PulmonarySharedControl
Smoking_Status never
History_of_chronic_lung_disease Yes
Chronic??lung_disease(s)_present Asthma
Experienced_a_cough_at_least_4_days_a_week_for_at_ No
Experienced_breathlessness_that_limits_ability_to_ None
Used_or_been_prescribed_oxygen No
Had_a_transplant_(bone_marrow_peripheral_stem_cell No
Active_cancer_or_cancer_diagnosis_in_the_past_2_ye No
Family_history_of_pulmonary_fibrosis No
  • Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
  • All donor consents include statements on the following:
    • Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
    • Changing some of the genetic code or sequence within these cells
    • Using cells to test or select drugs to treat disease
    • Transplanting cells or resulting products to humans or animals
      Distributing cells widely (nationally and internationally) for research, training or commercial medical product development
    • Future research and uses unforeseen at this time
  • Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
  • Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.

Characteristics

Please refer this page for some characteristics data.

Documents

Protocol

SDS

Others